Prognostic Significance of Cytoplasmic P53 Overexpression in Colorectal Cancer. An Immunohistochemical Analysis
Overview
Authors
Affiliations
p53 overexpression was studied by immunohistochemistry in 96 consecutive colorectal cancer patients, subdividing positive specimens according to two staining patterns: cytoplasmic or nuclear. Forty-seven per cent of the cases were p53 positive, a significant correlation being found with Dukes' stage (P = 0.0036). A prevalence of nuclear staining was observed in Dukes' B and cytoplasmic in Dukes' D stages. After 36 months, 23% of the patients had a recurrence, and 45% were p53 positive, all Dukes' C-D stage with cytoplasmic staining. The Kaplan-Meier curve showed a significant correlation between p53 cytoplasmic staining and disease-free survival period (P = 0.002). With respect to disease-free survival, the Cox proportional hazard regression test, comparing p53 positivity with Dukes' stage, showed the latter to be the most significant variable. In our series of patients, advanced Dukes' stage tumours were localised in the right colon, where a higher percentage of p53 positivity (67% versus 40% of the left side), as well as a higher frequency of cytoplasmic staining was observed. In conclusion, from the data obtained, a strong correlation between p53 cytoplasmic staining and patient prognosis is clearly indicated.
Cytoplasmic p53 aggregates accumulated in p53-mutated cancer correlate with poor prognosis.
Iwahashi N, Ikezaki M, Komohara Y, Fujiwara Y, Noguchi T, Nishioka K PNAS Nexus. 2023; 1(3):pgac128.
PMID: 36741442 PMC: 9896898. DOI: 10.1093/pnasnexus/pgac128.
Popescu-Valceanu H, Stoicea M, Enache V, Bratu R, Mustatea P, Dragut R Rom J Morphol Embryol. 2023; 63(3):521-528.
PMID: 36588490 PMC: 9926153. DOI: 10.47162/RJME.63.3.06.
Gunasekaran S, Venkatachalam K, Namasivayam N Mol Cell Biochem. 2018; 451(1-2):117-129.
PMID: 29980883 DOI: 10.1007/s11010-018-3398-5.
The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment.
de Vries N, Swets M, Vahrmeijer A, Hokland M, Kuppen P Int J Mol Sci. 2016; 17(7).
PMID: 27367680 PMC: 4964406. DOI: 10.3390/ijms17071030.
Wang C, Chien K, Wang C, Liu H, Cheng C, Chang Y Mol Cell Proteomics. 2012; 11(11):1105-22.
PMID: 22843992 PMC: 3494185. DOI: 10.1074/mcp.M111.016592.